Please try another search
Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide. The company offers ELILSA, an assay kit to quantitatively measure targeted substances; and support research services on Alzheimer’s disease, metabolic syndrome, and cancer, as well as customized services for production of customized antibodies and development of ELISA systems. It also provides LipoSEARCH, a customized services for profiling and analyzing of lipoprotein through gel-filtration high performance liquid chromatography method that can profile various clinical samples, such as tiny plasma or serum samples from both small animals and human beings for broad range of research fields including lipid metabolism, development of drugs for life-style related diseases, development of functional supplemental foods, and clinical studies. In addition, the company offers LipoTEST, a support tool for diagnostic and health checks at animal clinics; and customized biomarker testing services for Life-style related diseases. Further, it operates protein production business using transgenic silkworms for manufacturing of antibodies for research reagents and diagnostic products; human collagen for cosmetic materials; development of proteins for use in drugs; and other proteins production. The company was incorporated in 1982 and is headquartered in Fujioka, Japan.
Name | Age | Since | Title |
---|---|---|---|
Masato Nakagawa | 62 | 2008 | MD, Head of Business Operations and Business Group Management Headquarters & Director |
Masahiro Maeda | 67 | 2001 | GM of Antibody Business Headquarters and Clinical Testing Business & Director |
Tsutomu Seito | 80 | 1982 | President & Representative Director |
Shoko Onodera | 63 | 2001 | GM of Human Resources, General Affairs and Internal Audit Office & Director |
Kenji Fukunaga | 55 | 2011 | Independent Outside Director |
Nobuaki Yoshida | 76 | 2022 | Auditor |
Sadahiro Okazumi | 57 | 2018 | Corporate Auditor |
Takeshi Tayama | 53 | 2014 | External Auditor |
Ikkei Kojima | 41 | 2019 | Independent External Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review